Recent advancements have identified the CoQ10/FSP1 axis as a key defense mechanism against ferroptosis, offering a promising therapeutic target for hepatocellular carcinoma (HCC) by suppressing tumor growth through ferroptosis induction. Here, AIFM2 is linked to hepatocellular carcinoma.